Journal
BIOENGINEERING & TRANSLATIONAL MEDICINE
Volume 5, Issue 1, Pages -Publisher
WILEY
DOI: 10.1002/btm2.10142
Keywords
bacteriophage; biomaterials; drug delivery; immunology; nanotechnology; phage display; vaccine
Funding
- National Institute of Biomedical Imaging and Bioengineering [R01EB026896, R01EB027143]
- United States Department of Veteran Affairs [1I01BX003690]
Ask authors/readers for more resources
Bacteriophages, or phages, are viruses that specifically infect bacteria and coopt the cellular machinery to create more phage proteins, eventually resulting in the release of new phage particles. Phages are heavily utilized in bioengineering for applications ranging from tissue engineering scaffolds to immune signal delivery. Of specific interest to vaccines and immunotherapies, phages have demonstrated an ability to activate both the innate and adaptive immune systems. The genome of these viral particles can be harnessed for DNA vaccination, or the surface proteins can be exploited for antigen display. More specifically, genes that encode an antigen of interest can be spliced into the phage genome, allowing antigenic proteins or peptides to be displayed by fusion to phage capsid proteins. Phages therefore present antigens to immune cells in a highly ordered and repetitive manner. This review discusses the use of phage with adjuvanting activity as antigen delivery vehicles for vaccination against infectious disease and cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available